Sotera Health Company (SHC) Profit Margin
Sotera Health Company (SHC) net profit margin by fiscal period. Analyze profit margins in Excel with MarketXLS.
Profit Margin Data
| Period | Net Profit Margin |
|---|---|
| 2021-12-31 | 12.55% |
| 2022-12-31 | -23.27% |
| 2023-12-31 | 4.90% |
| 2024-12-31 | 4.03% |
| 2025-12-31 | 6.70% |
How SHC compares with sector peers
| Symbol | Company | Net profit margin (latest fiscal year) |
|---|---|---|
| VCYT | Veracyte Inc. | 12.83% |
| ALGN | Align Technology Inc. | 10.17% |
| PODD | Insulet Corporation | 9.12% |
| ALNY | Alnylam Pharmaceuticals Inc. | 8.45% |
| ABBV | AbbVie Inc. | 6.91% |
These are five companies in the same sector as SHC with a comparable annual net profit margin. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Sotera Health Company Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Profit_Margin("SHC", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | SHC | $18.34 | -0.60% | 1.18M |
| 3 | ||||
| 4 | ||||
| 5 |